Stage-dependent immunity orchestrates AQP4 antibody-guided NMOSD pathology: a role for netting neutrophils with resident memory T cells in situ
Akihiro Nakajima,Fumihiro Yanagimura,Etsuji Saji,Hiroshi Shimizu,Yasuko Toyoshima,Kaori Yanagawa,Musashi Arakawa,Mariko Hokari,Akiko Yokoseki,Takahiro Wakasugi,Kouichirou Okamoto,Hirohide Takebayashi,Chihiro Fujii,Kyoko Itoh,Yo-ichi Takei,Shinji Ohara,Mitsunori Yamada,Hitoshi Takahashi,Masatoyo Nishizawa,Hironaka Igarashi,Akiyoshi Kakita,Osamu Onodera,Izumi Kawachi
DOI: https://doi.org/10.1007/s00401-024-02725-x
IF: 15.887
2024-04-26
Acta Neuropathologica
Abstract:Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease of the CNS characterized by the production of disease-specific autoantibodies against aquaporin-4 (AQP4) water channels. Animal model studies suggest that anti-AQP4 antibodies cause a loss of AQP4-expressing astrocytes, primarily via complement-dependent cytotoxicity. Nonetheless, several aspects of the disease remain unclear, including: how anti-AQP4 antibodies cross the blood–brain barrier from the periphery to the CNS; how NMOSD expands into longitudinally extensive transverse myelitis or optic neuritis; how multiphasic courses occur; and how to prevent attacks without depleting circulating anti-AQP4 antibodies, especially when employing B-cell-depleting therapies. To address these knowledge gaps, we conducted a comprehensive 'stage-dependent' investigation of immune cell elements in situ in human NMOSD lesions, based on neuropathological techniques for autopsied/biopsied CNS materials. The present study provided three major findings. First, activated or netting neutrophils and melanoma cell adhesion molecule-positive (MCAM + ) helper T (T H ) 17/cytotoxic T (T C ) 17 cells are prominent, and the numbers of these correlate with the size of NMOSD lesions in the initial or early-active stages. Second, forkhead box P3-positive (FOXP3 + ) regulatory T (T reg ) cells are recruited to NMOSD lesions during the initial, early-active or late-active stages, suggesting rapid suppression of proinflammatory autoimmune events in the active stages of NMOSD. Third, compartmentalized resident memory immune cells, including CD103 + tissue-resident memory T (T RM ) cells with long-lasting inflammatory potential, are detected under "standby" conditions in all stages. Furthermore, CD103 + T RM cells express high levels of granzyme B/perforin-1 in the initial or early-active stages of NMOSD in situ. We infer that stage-dependent compartmentalized immune traits orchestrate the pathology of anti-AQP4 antibody-guided NMOSD in situ. Our work further suggests that targeting activated/netting neutrophils, MCAM + T H 17/T C 17 cells, and CD103 + T RM cells, as well as promoting the expansion of FOXP3 + T reg cells, may be effective in treating and preventing relapses of NMOSD.
pathology,neurosciences,clinical neurology